广州白云山医药集团股份有限公司白云山制药总厂
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
363
NMPA:363
Drug Approvals
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20247264
- Approval Date
- Nov 1, 2024
NMPA
Tabellae Bergenini Compositae
- Product Name
- 复方岩白菜素片
- Approval Number
- 国药准字H44023911
- Approval Date
- Oct 10, 2024
NMPA
Pyritinol Hydrochloride Tablets
- Product Name
- 盐酸吡硫醇片
- Approval Number
- 国药准字H44021501
- Approval Date
- Oct 10, 2024
NMPA
Labetalol Hydrochloride Tablets
- Product Name
- 盐酸拉贝洛尔片
- Approval Number
- 国药准字H44024809
- Approval Date
- Oct 10, 2024
NMPA
Ketotifen Fumarate Tablets
- Product Name
- 富马酸酮替芬片
- Approval Number
- 国药准字H44020957
- Approval Date
- Oct 10, 2024
NMPA
Levamisole Hydrochloride Tablets
- Product Name
- 盐酸左旋咪唑片
- Approval Number
- 国药准字H44021500
- Approval Date
- Oct 10, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 37
- Next
Clinical Trials
No trials found
News
No news found